2022.04.19

A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant

This work is published on EMBO Molecular Medicine in February, 2022. It is a cooperation with Prof. Pan-Chyr Yang from Department of Internal Medicine, National Taiwan University Hospital, and Oneness Biotech. Co., Ltd..

The BSL-3 Research and Analysis Laboratory helped to screen and confirm the efficiency of siRNA against authentic SARS-CoV-2 variants.